{"disease":{"id":"macrophage-activation-syndrome","name":"macrophage activation syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03827343","title":"Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06339177","title":"Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05611710","title":"Anakinra in Dengue With Hyperinflammation ( AnaDen )","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT04339712","title":"Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":false},{"nct_id":"NCT06405152","title":"Assessment of Macrophage Activation syndromE in STill's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT05137496","title":"Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03332225","title":"A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":false},{"nct_id":"NCT05001737","title":"Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT06992505","title":"Assessment of Macrophage Activation syndromE in STill's Disease in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT03721809","title":"Characterization of the Inflammatory Profile of Patients With Macrophage Activation Syndrome Secondary to Bacterial Sepsis","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT03311854","title":"A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT02780583","title":"Treatment of Macrophage Activation Syndrome (MAS) With Anakinra","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}